{"text": "cbio biib catalyst biosciences regains rights to cb 2782 peg for the treatment of dry amd expands cbios complement portfolio in ophthalmology"}
{"text": "first out biib biogen shareholder notice"}
{"text": "major bottom forming on biib here have bids open at 190 for that monthly tap"}
{"text": "stock biib realtime trend sell buy 21 51 sell 78 49 try now the best pivot point calculator tradingview stocks stockstowatch"}
{"text": "cbio biib biogen has returned the rights for further development on cb 2782 peg and has ended the collaboration on other potential amd treatments"}
{"text": "cbio not sure why folks are buying on this its actually a negative in that biib doesn t see value in them anymore and is relinquiishing their rights to it"}
